Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$814M |
| 3 |
NVIDIA
NVDA
|
+$700M |
| 4 |
Broadcom
AVGO
|
+$647M |
| 5 |
Shopify
SHOP
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$701M |
| 2 |
Johnson & Johnson
JNJ
|
+$685M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$484M |
| 4 |
Meta Platforms (Facebook)
META
|
+$407M |
| 5 |
HubSpot
HUBS
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.47% |
| 2 | Financials | 12.85% |
| 3 | Industrials | 11.86% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEE.PRS
1801
NextEra Energy 7.299% Corporate Units
NEE.PRS
$2.12B
| $9.28M | ﹤0.01% |
197,000
+59,000
| +43% | +$2.8M |
|
1802
ArcBest
ARCB
$3.27B
| $9.27M | ﹤0.01% |
120,372
-37,424
| -24% | -$2.44M |
|
|
RWT
1803
Redwood Trust
RWT
$600M
| $9.25M | ﹤0.01% |
1,565,717
-238,399
| -13% | -$1.35M |
|
|
EOI
1804
Eaton Vance Enhanced Equity Income Fund
EOI
$832M
| $9.19M | ﹤0.01% |
439,492
-11,433
| -3% | -$220K |
|
1805
First Commonwealth Financial
FCF
$2.19B
| $9.18M | ﹤0.01% |
565,610
-75,375
| -12% | -$1.16M |
|
1806
Olin
OLN
$2.17B
| $9.18M | ﹤0.01% |
456,747
+48,164
| +12% | +$1M |
|
1807
Noble Corp
NE
$7.03B
| $9.17M | ﹤0.01% |
345,208
-95,096
| -22% | -$2.28M |
|
1808
Bio-Rad Laboratories Class A
BIO
$9.61B
| $9.15M | ﹤0.01% |
37,925
-2,061
| -5% | -$487K |
|
|
HFRO
1809
Highland Opportunities and Income Fund
HFRO
$398M
| $9.07M | ﹤0.01% |
1,745,118
-16,759
| -1% | -$84.7K |
|
1810
Minerals Technologies
MTX
$2.27B
| $9.07M | ﹤0.01% |
164,725
-74,375
| -31% | -$4.19M |
|
1811
Diamondrock Hospitality Co
DRH
$2.51B
| $9.07M | ﹤0.01% |
1,183,704
-5,423,740
| -82% | -$40.4M |
|
1812
Snap
SNAP
$8.83B
| $9.06M | ﹤0.01% |
1,042,943
+206,726
| +25% | +$1.72M |
|
|
PKST
1813
DELISTED
Peakstone Realty Trust
PKST
| $9.05M | ﹤0.01% |
685,454
-146,861
| -18% | -$1.8M |
|
|
PDT
1814
John Hancock Premium Dividend Fund
PDT
$627M
| $9.05M | ﹤0.01% |
687,451
+16,425
| +2% | +$209K |
|
1815
Fidus Investment
FDUS
$753M
| $9.02M | ﹤0.01% |
446,703
+9,637
| +2% | +$188K |
|
1816
Summit Therapeutics
SMMT
$11.8B
| $9.02M | ﹤0.01% |
424,027
+34,322
| +9% | +$783K |
|
|
CTO
1817
CTO Realty Growth
CTO
$824M
| $9.02M | ﹤0.01% |
522,721
+17,334
| +3% | +$313K |
|
1818
Bloomin' Brands
BLMN
$943M
| $9M | ﹤0.01% |
1,045,557
+84,692
| +9% | +$680K |
|
|
MPT
1819
Medical Properties Trust
MPT
$2.44B
| $8.99M | ﹤0.01% |
2,086,590
+1,228
| +0.1% | +$6.07K |
|
1820
Vail Resorts
MTN
$5.24B
| $8.98M | ﹤0.01% |
57,156
-4,052
| -7% | -$602K |
|
1821
Central Garden & Pet Co Class A
CENTA
$2.42B
| $8.96M | ﹤0.01% |
286,469
-92,232
| -24% | -$2.88M |
|
1822
Coty
COTY
$2.42B
| $8.96M | ﹤0.01% |
1,927,353
+165,399
| +9% | +$819K |
|
|
DCH
1823
Dauch Corp
DCH
$1.58B
| $8.95M | ﹤0.01% |
2,194,152
-80,270
| -4% | -$323K |
|
|
PRMB
1824
Primo Brands
PRMB
$8.97B
| $8.93M | ﹤0.01% |
301,535
+67,930
| +29% | +$2.17M |
|
|
AKRO
1825
DELISTED
Akero Therapeutics
AKRO
| $8.93M | ﹤0.01% |
167,305
+50,184
| +43% | +$2.28M |
|
Similar funds
Invesco's Q2 2025 Portfolio in Review
As of Q2 2025, Invesco held 3,922 positions worth $588B, up 11% from $528B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Invesco's Q2 2025 filing shows 165 new, 1,670 increased, 1,835 reduced and 165 closed positions. Its largest new stake was QXO Inc: 27,561,664 shares worth $594M. The largest sale was UnitedHealth, an estimated $701M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2025 buy was QXO Inc: 27,561,664 shares worth $594M.
- Invesco added most to Microsoft in Q2 2025, an estimated $1.45B increase.
- Invesco's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $701M.
- Invesco fully exited Discover Financial Services in Q2 2025, selling an estimated $484M.
- Invesco's ten largest holdings make up 20% of its $588B portfolio in Q2 2025.
- Invesco opened 165 new positions and closed 165 in Q2 2025.
- Invesco's portfolio value rose 11% quarter-over-quarter to $588B.
Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.